Glaucoma is a progressive condition where the internal pressure in the eye increases, causing damage to fibers in the optic nerve that can result in permanent loss of vision. Glaucoma is a leading cause of blindness and visual impairment in the United States today, affecting over two percent of the population over the age of 35. Individuals who are especially at high risk for glaucoma include: individuals with a family history of glaucoma; African Americans; diabetics and individuals who are very nearsighted or have had a previous eye injury.
CEI glaucoma specialists provide comprehensive services, including: glaucoma evaluation and testing; management of intraocular pressure; treatment to improve drainage of fluid from the eye, including surgery, laser treatments, and implants.
Laser Glaucoma procedures performed at CEI:
- Argon Laser Trabeculoplasty (ALT)
- Selective Laser Trabeculoplasty (SLT)
- Laser Peripheral Iridotomy (LPI)
- Argon Laser Peripheral Iridoplasty and Gonioplasty
- Trans-scleral Cyclophotocoagulation (CPC)
- Endoscopic Cyclophotocoagulation (ECP)
Surgical Glaucoma procedures performed at CEI:
- Aqueous Tube Shunts (Ahmed, Baerveldt, Molteno-3)
- Ex-Press Mini Shunt
- Trabectome (Ab interno trabeculotomy)
- Suture Canaloplasty
- Suprachoroidal stent (investigational)
- Schlemm's canal stent